| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 16 '26 | Option Exercise | 0.00 | 35,876 | 0 | 268,002 | Mar 18 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 16 '26 | Sale | 32.84 | 5,221 | 171,458 | 262,781 | Mar 18 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Dec 09 '25 | Sale | 31.21 | 19,517 | 609,087 | 241,132 | Dec 10 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Sep 16 '25 | Sale | 16.29 | 1,137 | 18,522 | 220,649 | Sep 16 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 19 '25 | Sale | 17.50 | 15,111 | 264,443 | 217,762 | Mar 19 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 16 '25 | Option Exercise | 0.00 | 64,924 | 0 | 232,873 | Mar 19 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Feb 28 '25 | Option Exercise | 0.00 | 24,799 | 0 | 209,301 | Mar 04 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 21 '24 | Sale | 7.68 | 4,578 | 35,159 | 165,661 | Mar 25 12:00 AM |
| AXGN | DeVinney Erick Wayne | Chief Innovation Officer | Mar 16 '24 | Option Exercise | 0.00 | 37,350 | 0 | 180,615 | Mar 25 12:00 AM |
| AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | Mar 16 '23 | Option Exercise | 0.00 | 17,800 | 0 | 113,596 | Mar 20 12:00 AM |
| AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 27 '22 | Option Exercise | 2.45 | 41,500 | 101,800 | 116,752 | Dec 29 12:00 AM |